6533b821fe1ef96bd127c1d8
RESEARCH PRODUCT
Prolonged anticoagulant treatment in patients with cancer: Where do we stand?
Mariasanta NapolitanoSergio Siragusasubject
medicine.medical_specialtymedicine.drug_classLow molecular weight heparin030204 cardiovascular system & hematologyGastroenterology03 medical and health sciences0302 clinical medicineTinzaparinRecurrenceNeoplasmsInternal medicineHumansMedicineCancer associated thrombosisIn patientbusiness.industryLow molecular weight heparinCancer associated thrombosiBleedingAnticoagulantsCancerHematologyTinzaparinmedicine.diseaseAnticoagulant therapy030220 oncology & carcinogenesisbusinessyear | journal | country | edition | language |
---|---|---|---|---|
2017-07-26 |